EFFECTOR CD4+T CELLS, RATHER THAN CD8+, INCREASE THE EFFICACY OF ANTIBODY-DRIVEN TUMOR IMMUNITY

被引：0
|
作者：
Gutwillig, A. [1 ]
Rasoulouniriana, D. [1 ]
Santana-Magal, N. [1 ]
Farhat, L. [1 ]
Tal, L. [1 ]
Rider, P. [1 ]
Carmi, Y. [1 ]
机构：
[1] Tel Aviv Univ, Pathol, Tel Aviv, Israel
来源：
HUMAN GENE THERAPY | 2019年 / 30卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
ICLEa19-00
引用
收藏
页码：A21 / A21
页数：1
相关论文
共 50 条
  • [1] Effector and memory CD8+ T cells as seen in immunity to malaria
    Morrot, A
    Zavala, F
    IMMUNOLOGICAL REVIEWS, 2004, 201 : 291 - 303
  • [2] Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cells
    Church, Sarah E.
    Jensen, Shawn M.
    Antony, Paul A.
    Restifo, Nicholas P.
    Fox, Bernard A.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2014, 44 (01) : 69 - 79
  • [3] The Significance of Tumor Necrosis Factor Receptor Type II in CD8+ Regulatory T Cells and CD8+ Effector T Cells
    Ye, Lin-Lin
    Wei, Xiao-Shan
    Zhang, Min
    Niu, Yi-Ran
    Zhou, Qiong
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [4] Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity
    Hinrichs, Christian S.
    Borman, Zachary A.
    Cassard, Lydie
    Gattinoni, Luca
    Spolski, Rosanne
    Yu, Zhiya
    Sanchez-Perez, Luis
    Muranski, Pawel
    Kern, Steven J.
    Logun, Carol
    Palmer, Douglas C.
    Ji, Yun
    Reger, Robert N.
    Leonard, Warren J.
    Danner, Robert L.
    Rosenberg, Steven A.
    Restifo, Nicholas P.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (41) : 17469 - 17474
  • [5] The function and dysfunction of memory CD8+ T cells in tumor immunity
    Reading, James L.
    Galvez-Cancino, Felipe
    Swanton, Charles
    Lladser, Alvaro
    Peggs, Karl S.
    Quezada, Sergio A.
    IMMUNOLOGICAL REVIEWS, 2018, 283 (01) : 194 - 212
  • [6] Activation phenotype, rather than central-or effector-memory phenotype, predicts the recall efficacy of memory CD8+ T cells
    Hikono, Hirokazu
    Kohlmeier, Jacob E.
    Takamura, Shiki
    Wittmer, Susan T.
    Roberts, Alan D.
    Woodland, David L.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (07): : 1625 - 1636
  • [7] CD4+T cells in antitumor immunity
    Montauti, Elena
    Oh, David Y.
    Fong, Lawrence
    TRENDS IN CANCER, 2024, 10 (10) : 969 - 985
  • [8] Calnexin Impairs the Antitumor Immunity of CD4+ and CD8+ T Cells
    Chen, Yichen
    Ma, Da
    Wang, Xi
    Fang, Juan
    Liu, Xiangqi
    Song, Jingjing
    Li, Xinye
    Ren, Xianyue
    Li, Qiusheng
    Li, Qunxing
    Wen, Shuqiong
    Luo, Liqun
    Xia, Juan
    Cui, Jun
    Zeng, Gucheng
    Chen, Lieping
    Cheng, Bin
    Wang, Zhi
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (01) : 123 - 135
  • [9] Not all effector CD8+ T cells are alike
    Drake, DR
    Braciale, TJ
    MICROBES AND INFECTION, 2003, 5 (03) : 199 - 204
  • [10] CD8+ T cell tolerance to a tumor-associated antigen is maintained at the level of expansion rather than effector function
    Öhlén, C
    Kalos, M
    Cheng, LE
    Shur, AC
    Hong, DJ
    Carson, BD
    Kokot, NCT
    Lerner, CG
    Sather, BD
    Huseby, ES
    Greenberg, PD
    JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (11): : 1407 - 1418
12345